BLEEDING DUODENAL-ULCER - ROLE OF GASTRIC-ACID HYPERSECRETION

被引:14
作者
COLLEN, MJ
KALLOO, AN
SHERIDAN, MJ
机构
[1] INOVA HLTH SYST, INST MED RES, FALLS CHURCH, VA USA
[2] LOMA LINDA UNIV, MED CTR, DEPT MED, DIV GASTROENTEROL, LOMA LINDA, CA 92350 USA
关键词
DUODENAL ULCER; BLEEDING; ACID HYPERSECRETION;
D O I
10.1007/BF01307543
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Basal gastric acid output was analyzed prospectively in 110 patients with endoscopically documented duodenal ulcer disease to determine the frequency of gastric acid hypersecretion in patients with bleeding versus nonbleeding ulcers. Thirty-eight patients with stigmata of an actively or recently bleeding duodenal ulcer had a mean basal output of 12.6 +/- 8.9 meq/hr. In comparison, 72 patients with nonbleeding duodenal ulcers (and no history of prior bleeding) had a significantly lower mean basal acid output of 8.7 +/- 7.5 meq/hr (P < 0.05). Twenty-four of the 38 patients (63%) with bleeding and 28 of the 72 (39%) with nonbleeding duodenal ulcers had gastric acid hypersecretion, defined as a basal acid output of greater than 10.0 meq/hr. There was a statistically significant association between bleeding duodenal ulcer and acid hypersecretion (P = 0.01). All 110 patients were treated with standard doses of H-2-receptor antagonists for eight weeks. In that time, 87 patients healed and 23 patients (14 with prior bleeding and nine with nonbleeding duodenal ulcers) remained unhealed. Significantly more patients who had bled had nonhealing duodenal ulcers (P = 0.004). Irrespective of bleeding history, all 23 patients with nonhealing duodenal ulcers at eight weeks had basal acid outputs of greater than 10.0 meq/hr (range 10.1-49.1 meq/hr). These 23 patients with nonhealing duodenal ulcers were treated with increased doses of ranitidine (mean 690 mg/day, range 600-1200 mg/day) for up to eight additional weeks. All were observed to have complete endoscopic healing documented within that period. These results suggest that bleeding duodenal ulcers are often associated with gastric acid hypersecretion and that these ulcers are less likely to heal after eight weeks of standard dose H-2-receptor antagonist therapy. Similarly, nonbleeding duodenal ulcers associated with gastric acid hypersecretion are also less likely to heal after standard doses of antisecretory therapy.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 38 条
  • [1] CIMETIDINE AND TRANEXAMIC ACID IN THE TREATMENT OF ACUTE UPPER-GASTROINTESTINAL-TRACT BLEEDING
    BARER, D
    OGILVIE, A
    HENRY, D
    DRONFIELD, M
    COGGON, D
    FRENCH, S
    ELLIS, S
    ATKINSON, M
    LANGMAN, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (26) : 1571 - 1575
  • [2] CAPRIA A, 1987, INT J TISSUE REACT, V9, P439
  • [3] CARGILL JM, 1978, LANCET, V2, P1113
  • [4] PLACEBO-CONTROLLED TRIAL WITH THE SOMATOSTATIN ANALOG SMS-201-995 IN PEPTIC-ULCER BLEEDING
    CHRISTIANSEN, J
    OTTENJANN, R
    VONARX, F
    [J]. GASTROENTEROLOGY, 1989, 97 (03) : 568 - 574
  • [5] REFRACTORY DUODENAL-ULCERS (NONHEALING DUODENAL-ULCERS WITH STANDARD DOSES OF ANTISECRETORY MEDICATION)
    COLLEN, MJ
    STANCZAK, VJ
    CIARLEGLIO, CA
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (02) : 233 - 237
  • [6] COLLEN MJ, 1989, AM J GASTROENTEROL, V84, P873
  • [7] COMPARISON OF RANITIDINE AND CIMETIDINE IN THE TREATMENT OF GASTRIC HYPERSECRETION
    COLLEN, MJ
    HOWARD, JM
    MCARTHUR, KE
    RAUFMAN, JP
    CORNELIUS, MJ
    CIARLEGLIO, CA
    GARDNER, JD
    JENSEN, RT
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) : 52 - 58
  • [8] COLLEN MJ, 1990, GASTROENTEROLOGY, V84, P872
  • [9] TREATMENT WITH HISTAMINE-H-2 ANTAGONISTS IN ACUTE UPPER GASTROINTESTINAL HEMORRHAGE - IMPLICATIONS OF RANDOMIZED TRIALS
    COLLINS, R
    LANGMAN, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (11) : 660 - 666
  • [10] CZAJA AJ, 1976, ARCH SURG-CHICAGO, V111, P243